General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-14 | 2024-03 | -0.51 | -0.68 | -0.17 | -33.33% |
2024-04-04 | 2023-12 | -0.89 | N/A | N/A | N/A |
2023-11-14 | 2023-09 | -1.14 | -1.14 | N/A | N/A |
2023-11-14 | 2023-09 | -1.14 | N/A | N/A | N/A |
2023-08-21 | 2023-06 | -1.5 | -1.33 | 0.17 | 11.33% |
2023-08-21 | 2023-06 | -1.5 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-05-22 | CLAIBORNE CARY J | Chief Executive Officer | 1.52M | Stock Award(Grant) |
2018-07-30 | GILLILAND ROBERTSON H. | Director | 0.00 | Purchase |
2018-07-30 | GOODMAN TONY | Director | 8.76K | Purchase |
2021-10-03 | JOHNSON BANKOLE A | Officer | 0.00 | Sale |
2021-12-29 | NEWMAN JAMES W. JR. | Director | 0.00 | Purchase |
2023-09-28 | SCHUYLER KEVIN | Director | 6.59K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Manchester Capital Management, LLC | 48.10K | 10.01K | 3.95% |
2023-06-29 | Vanguard Group Inc | 8.13K | 1.69K | 0.67% |
2023-06-29 | Blackrock Inc. | 7.77K | 1.62K | 0.64% |
2023-06-29 | Susquehanna International Group, LLP | 7.21K | 1.50K | 0.59% |
2023-06-29 | Geode Capital Management, LLC | 5.50K | 1.14K | 0.45% |
2023-06-29 | Renaissance Technologies, LLC | 4.28K | 891.00 | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 8.13K | 1.69K | 0.67% |
2023-05-30 | Fidelity Extended Market Index Fund | 2.92K | 766.00 | 0.24% |
2023-05-30 | Fidelity Series Total Market Index Fund | 957.00 | 251.00 | 0.08% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 662.00 | 174.00 | 0.05% |
2023-05-30 | Fidelity Total Market Index Fund | 511.00 | 134.00 | 0.04% |
Split | Date |
---|---|
1 : 25 | 2023-08-07 |
Trump represents who? American are embarrassed!
Can someone tweet Trump to mention this test. He has blocked me:(
David wtf you are doing here? You have the best invention inside your skull. Dierria
The Assure COVID-19 IgG/IgM Rapid Test Device is currently the only FDA authorized COVID-19 POC serology test and is available by prescription only. The FDA continues to work with test developers to expand access to COVID-19 testing.
This can be bought by pig companies which already have the production in place.
Haters posting cute little pics. How’s that read working out for ya. Hahaha
Haters be wasting time hating
Instead of changing to a positive vibe getting that profit when it’s time to be taking they blow up their account from never paying enough attention
They rather hate then educate themselves with all the knowledgeable information......
I am adding more now
Search Results
Featured snippet from the web
Adial Pharmaceuticals Inc (NASDAQ:ADIL)
The 1 analysts offering 12-month price forecasts for Adial Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +309.84% increase from the last price of 1.22.
Search Results
Featured snippet from the web
Adial Pharmaceuticals Inc (NASDAQ:ADIL)
The 1 analysts offering 12-month price forecasts for Adial Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +309.84% increase from the last price of 1.22.
Search Results
Featured snippet from the web
Adial Pharmaceuticals Inc (NASDAQ:ADIL)
The 1 analysts offering 12-month price forecasts for Adial Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +309.84% increase from the last price of 1.22.
Search Results
Featured snippet from the web
Adial Pharmaceuticals Inc (NASDAQ:ADIL)
The 1 analysts offering 12-month price forecasts for Adial Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +309.84% increase from the last price of 1.22.